Mountain Crest Acquisition

YTD

ALL

Why Robinhood?

You can watch MCAD and buy or sell other stocks, ETFs, and their options commission-free!

About MCAD

Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions.

CEO

Craig R. Jalbert

CEOCraig R. Jalbert

Employees

—

Employees—

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2015

Founded2015

Employees

—

Employees—

MCAD Key Statistics

Market cap

5.40K

Market cap5.40K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

15.30K

Average volume15.30K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.001

52 Week high$0.001

52 Week low

—

52 Week low—

Stock Snapshot

With a market cap of 5.4K, Mountain Crest Acquisition(MCAD) trades at $10.43.

On 2025-12-18, Mountain Crest Acquisition(MCAD) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Mountain Crest Acquisition(MCAD) stock has reached 0, versus its average volume of 15.3K.

People also own

Based on the portfolios of people who own MCAD. This list is generated using Robinhood data, and it’s not a recommendation.